Abstract
Purpose of Review
This review discusses the epidemiology, microbiology and pathogenesis, prevention, diagnosis, and treatment of coccidioidomycosis in solid organ transplant recipients.
Recent Findings
Coccidioidomycosis is associated with a high mortality in solid organ transplant recipients than in immunocompetent individuals. Within the endemic area, strategies to reduce the incidence and mortality among solid organ transplant recipients include pretransplantation screening and treatment of coccidioidomycosis among donors and recipients, use of universal azole prophylaxis after transplantation, and more aggressive treatment of asymptomatic or primary pulmonary coccidioidomycosis after transplantation.
Summary
Coccidioidomycosis is an endemic infection in the southwestern United States that is associated with high rates of dissemination and mortality among solid organ transplant recipients. Patients can acquire coccidioidomycosis after transplantation via primary infection after transplantation, reactivation of prior infection, or infection acquired from the transplanted organ. Although some solid organ transplant recipients with coccidioidomycosis may be asymptomatic, in general, solid organ transplant recipients have more severe disease and a higher mortality rate than immunocompetent persons. Various strategies have been used to reduce the incidence and mortality among solid organ transplant recipients. Fluconazole is commonly used as the first-line treatment of asymptomatic or primary pulmonary coccidioidomycosis, but other azole therapy may be useful in patients intolerant to fluconazole. In patients with rapidly progressive coccidioidomycosis, amphotericin B is often used first, followed by fluconazole.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12281-021-00425-7/MediaObjects/12281_2021_425_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12281-021-00425-7/MediaObjects/12281_2021_425_Fig2_HTML.png)
Similar content being viewed by others
Abbreviations
- EIA:
-
Enzyme-linked immunosorbent assay
- CF:
-
Complement fixation
- ID:
-
Immunodiffusion
- IgM:
-
Immunoglobulin M
- IgG:
-
Immunoglobulin G
- ATS:
-
American Thoracic Society
- IDSA:
-
The Infectious Disease Society of America
- AST:
-
American Society of Transplantation
- CDC:
-
Centers of Disease Control and Prevention
- HIV:
-
Human immunodeficiency virus
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Cohen IM, et al. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982;142(3):489–94.
Holt CD, et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis. 1997;24(2):216–21.
Valley Fever Maps. Available from: https://www.cdc.gov/fungal/diseases/coccidioidomycosis/maps.html.
2019 Annual Tables of Infectious Disease Data. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, CDC Division of Health Informatics and Surveillance: Atlanta.
Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33(9):1536–44.
Blair JE. Coccidioidomycosis in liver transplantation. Liver Transpl. 2006;12(1):31–9.
Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci. 2007;1111:365–76.
Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis. 2003;5(1):3–8.
Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant. 2006;6(2):340–5.
Bergstrom L, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 2004;50(6):1959–66.
Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119(11):964–9.
Wheeler C, Lucas KD, Mohle-Boetani JC. Rates and risk factors for Coccidioidomycosis among prison inmates, California, USA, 2011. Emerg Infect Dis. 2015;21(1):70–5.
Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993;94(3):235–40.
Fish DG, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore). 1990;69(6):384–91.
Woods CW, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994–1997: incidence, risk factors, and prevention. J Infect Dis. 2000;181(4):1428–34.
Leake JA, et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996–1997. J Infect Dis. 2000;181(4):1435–40.
Rosenstein NE, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996. Clin Infect Dis. 2001;32(5):708–14.
Prevention, C.f.D.C.a., Biology of Coccidioidomycosis. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/pdf/coccidiomycosis-lifecycle508c.pdf.
Stevens DA. Coccidioidomycosis. N Engl J Med. 1995;332(16):1077–82.
Hector RF, Laniado-Laborin R. Coccidioidomycosis–a fungal disease of the Americas. PLoS Med. 2005;2(1):e2.
Smith CE, Beard RR, et al. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health Nations Health. 1946;36(12):1394–402.
Nokes BT, Blair JE. Coccidioidomycosis in transplantation. In: Morris MI, Kotton CN, Wolfe C, editors. emerging transplant infections: clinical challenges and implications. Cham: Springer International Publishing; 2020. p. 1–18.
Hung CY, et al. A review of innate and adaptive immunity to coccidioidomycosis. Med Mycol. 2019;57(Supplement_1):S85–92.
Diep AL and Hoyer KK. Host Response to coccidioides infection: fungal immunity. Front Cell Infect Microbiol. 2020;10(692).
Castro-Lopez N and Hung CY. Immune response to coccidioidomycosis and the development of a vaccine. Microorganisms. 2017;5(1).
Ampel NM. The complex immunology of human coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:245–58.
van Besouw NM, et al. Tapering immunosuppressive therapy significantly improves in vivo cutaneous delayed type hypersensitivity responses. Transpl Immunol. 2008;19(3–4):229–34.
Galgiani JN, et al. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112–46.
Kotton CN, et al. Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report. Transplantation. 2006;81(1):132–4.
Carvalho C, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis. 2010;12(2):151–4.
Yoshino MT, Hillman BJ, Galgiani JN. Coccidioidomycosis in renal dialysis and transplant patients: radiologic findings in 30 patients. AJR Am J Roentgenol. 1987;149(5):989–92.
Chandler JW, Kalina RE, Milam DF. Coccidioidal choroiditis following renal transplantation. Am J Ophthalmol. 1972;74(6):1080–5.
Diaz MA et al. Coccidioides in lung transplant: case report. BMJ Case Rep. 2020;13(4).
Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987;83(5):949–52.
Theodoropoulos N, Angarone M. Photo quiz. Lip lesion in a solid organ transplant recipient. Clin Infect Dis. 2012;54(9):1332, 1373–13321374.
McAninch EA, et al. Coccidiomycosis thyroiditis in an immunocompromised host post-transplant: case report and literature review. J Clin Endocrinol Metab. 2014;99(5):1537–42.
Blair JE, et al. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006;162(5):317–24.
Mendoza N, Blair JE. The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients. Am J Transplant. 2013;13(4):1034–9.
Hage CA, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019;200(5):535–50.
Kuberski T, et al. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis. 2007;44(5):e50–4.
Durkin M, et al. Diagnosis of Coccidioidomycosis with use of the coccidioides antigen enzyme immunoassay. Clin Infect Dis. 2008;47(8):e69–73.
Thompson GR 3rd, et al. Serum (1->3)-β-D-glucan measurement in coccidioidomycosis. J Clin Microbiol. 2012;50(9):3060–2.
Jude CM, et al. Pulmonary coccidioidomycosis: pictorial review of chest radiographic and CT findings. Radiographics. 2014;34(4):912–25.
Phonphok K, et al. Screening Coccidioides serology in kidney transplant recipients: a 10-year cross-sectional analysis. Transpl Infect Dis. 2018;20(5):e12932.
Kahn A, Carey EJ, Blair JE. Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area. Liver Transpl. 2015;21(3):353–61.
• Asbury K, et al. De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant. Am J Transplant. 2019;19(9):2517–24. Incidence and presentation of de novo Coccidioidomycosis 1 year after transplantation.
Blair JE. Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. Transpl Infect Dis. 2004;6(2):74–6.
• Miller R, Assi M. Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13553. American Society of Transplantation recommendations on diagnosis, prevention, and treatment of Coccidioidomycosis in solid organ transplant recipients.
Kusne S, et al. Coccidioidomycosis transmission through organ transplantation: a report of the OPTN Ad Hoc Disease Transmission Advisory Committee. Am J Transplant. 2016;16(12):3562–7.
Nelson JK, et al. Donor-derived Coccidioides immitis endocarditis and disseminated infection in the setting of solid organ transplantation. Open Forum Infect Dis. 2016;3(3):ofw086.
Blair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis. 2007;9(1):78–82.
Dierberg KL, et al. Donor-derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis. 2012;14(3):300–4.
Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3(3):247–68.
Singh N, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice. Am J Transplant. 2012;12(9):2414–28.
Limper AH, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):96–128.
Kim MM, et al. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011;53(11):1060–6.
Puing AG, et al. Simultaneous coccidioidomycosis and phaeohyphomycosis in a kidney transplant recipient: a case report and literature review. Transpl Infect Dis. 2020;22(6):e13365.
Galgiani JN. Coccidioidomycosis. Curr Clin Top Infect Dis. 1997;17:188–204.
Kaplan JE, Zoschke D, Kisch AL. Withdrawal of immunosuppresive agents in the treatment of disseminated coccidioidomycosis. Am J Med. 1980;68(4):624–8.
Cervelli MJ. Fluconazole-sirolimus drug interaction. Transplantation. 2002;74(10):1477–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Fungal Infections in Transplantation
Rights and permissions
About this article
Cite this article
Agarwal, M., Nokes, B. & Blair, J.E. Coccidioidomycosis and Solid Organ Transplantation. Curr Fungal Infect Rep 15, 143–150 (2021). https://doi.org/10.1007/s12281-021-00425-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12281-021-00425-7